Slide1
Neoadjuvant and Adjuvant Treatment of Rectal Cancer
Slide2
Which fluoropyrimidine regimen did you use most frequently in the past year when prescribing neoadjuvant chemoradiation therapy for rectal cancer?
Slide3
Have you used oxaliplatin as part of neoadjuvant chemoradiation therapy for rectal cancer?
Slide4
Which treatment strategy are you most likely to recommend for a man in average health with a lesion 8 centimeters from the anal verge with the following characteristics?
Slide5
Which treatment strategy are you most likely to recommend for a man in average health with a lesion 8 centimeters from the anal verge with the following characteristics?
Slide6
Which treatment strategy are you most likely to recommend for a man in average health with a lesion 8 centimeters from the anal verge with the following characteristics?
Slide7
Which treatment strategy are you most likely to recommend for a man in average health with a lesion 8 centimeters from the anal verge with the following characteristics?
Slide8
Case 10: Postoperative adjuvant treatment of rectal cancer
Slide9
Case 10: Postoperative adjuvant treatment of rectal cancer